Literature DB >> 25591680

Prevalence of neuropathy in patients with impaired glucose tolerance using various electrophysiological tests.

Meena A Kannan1, Sailaja Sarva, Rukmini Mridula Kandadai, Vishnupriya Rao Paturi, Sheik Afshan Jabeen, Rupam Borgohain.   

Abstract

BACKGROUND: Neuropathy is often an associated feature woth long-standing type II diabetes mellitus. Neuropathy may occur even in subjects with impaired glucose tolerance.
OBJECTIVE: To study the prevalence of neuropathy using different electrophysiological techniques in subjects with impaired glucose tolerance (IGT) and no other identifiable cause of neuropathy.
MATERIALS AND METHODS: The study was conducted on 30 age-matched controls and 58 subjects with impaired oral glucose tolerance test (OGTT) attending diabetic awareness. Prediabetes was defined using World Health Organization (WHO) criteria. All subjects had normal glycosylated hemoglobin HbA (1c), vitamin B12 levels, and thyroid function. Neuropathy was evaluated by nerve conduction studies (NCS) performed on one upper and both lower limbs, dorsal sural nerve, medial and lateral planter nerve conductions using conventional techniques. Neuropathy was also evaluated by autononic function tests, and quantitative sensory testing (QST). The subjects were followed up for 4 years.
RESULTS: Out of 58 subjects, 19 (32.8%) had neuropathy. Nerve conduction studies showed evidence of neuropathy in 14 (24.13%) subjects, autonomic neuropathy was detected in 8 (13.8%), and QST was found to be abnormal in 16 (27.6%) subjects. Twenty subjects (34.5%) developed diabetes mellitus in the follow-up period.
CONCLUSIONS: Neuropathy was detected in 32.8% subjects with IGT. Small fiber neuropathy was most common. Of all the three parameters studied, QST was found to be most sensitive technique for the detection of neuropathy. Assessment of medial plantar and dorsal sural NCS increases the sensitivity in the detection of neuropathy.

Entities:  

Mesh:

Year:  2014        PMID: 25591680     DOI: 10.4103/0028-3886.149393

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  7 in total

1.  Distal lower limb strength is reduced in subjects with impaired glucose tolerance and is related to elevated intramuscular fat level and vitamin D deficiency.

Authors:  M M Almurdhi; N D Reeves; F L Bowling; A J M Boulton; M Jeziorska; R A Malik
Journal:  Diabet Med       Date:  2016-07-09       Impact factor: 4.359

Review 2.  Evidence for current diagnostic criteria of diabetes mellitus.

Authors:  Ritesh Kumar; Lakshmana Perumal Nandhini; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Muthupillai Vivekanadan
Journal:  World J Diabetes       Date:  2016-09-15

Review 3.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

Review 4.  Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.

Authors:  Varo Kirthi; Anugraha Perumbalath; Emily Brown; Sarah Nevitt; Ioannis N Petropoulos; Jamie Burgess; Rebecca Roylance; Daniel J Cuthbertson; Timothy L Jackson; Rayaz A Malik; Uazman Alam
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

5.  Effect of Almond Supplementation on Glycemia and Cardiovascular Risk Factors in Asian Indians in North India with Type 2 Diabetes Mellitus: A 24-Week Study.

Authors:  Seema Gulati; Anoop Misra; Ravindra M Pandey
Journal:  Metab Syndr Relat Disord       Date:  2017-01-04       Impact factor: 1.894

6.  Evaluation of the longitudinal deformation of the left ventricular myocardium in subjects with impaired fasting glucose with and without increased glycated hemoglobin.

Authors:  Niloofar Akhavan-Khaleghi; Ali Hosseinsabet
Journal:  Anatol J Cardiol       Date:  2018-01-24       Impact factor: 1.596

7.  Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort.

Authors:  Neeharika L Mathukumalli; Mridula R Kandadai; Jabeen A Shaik; Meena A Kanikannan; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.